Availability and dose response of phytophenols from a wheat bran rich cereal product in healthy human volunteers

Molecular Nutrition and Food Research

Volumn 61, Issue 3, 2017, Pages

  Neacsu, Madalina ^a   McMonagle, Jolene ^b   Fletcher, Reg J ^b   Hulshof, Toine ^b   Duncan, Sylvia H ^a   Scobbie, Lorraine ^a   Duncan, Gary J ^a   Cantlay, Louise ^a   Horgan, Graham ^c   de Roos, Baukje ^a   Duthie, Garry G ^a   Russell, Wendy R ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b Kellogg Europe   (Ireland)

^c BIOSS Aberdeen ^*  (United Kingdom)

Author keywords

Human dietary intervention; Metabolomics; Phytochemicals; Subclinical inflammation; Whole grain

Indexed keywords

COUMARIC ACID; FERULIC ACID; PHENOL DERIVATIVE;

ADULT; BIOAVAILABILITY; BLOOD; CHEMISTRY; COLON; DIETARY FIBER; DOSE RESPONSE; DRUG EFFECTS; FECES; FEMALE; FOOD GRAIN; HUMAN; MALE; METABOLISM; MIDDLE AGED; URINE;

ADULT; BIOLOGICAL AVAILABILITY; COLON; COUMARIC ACIDS; DIETARY FIBER; DOSE-RESPONSE RELATIONSHIP, DRUG; EDIBLE GRAIN; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOLS;

EID: 85014088439     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600202     Document Type: Article

References (36)

1. Anderson, J. W., Whole grains protect against atherosclerotic cardiovascular disease. Proc. Nutr. Soc. 2003, 62, 135–142.
2. Truswell, A. S., Cereal grains and coronary heart disease. Eur. J. Clin. Nutr. 2002, 56, 1–14.
3. Chatenoud, L., La Vecchia, C., Franceschi, S., Tavani, A. et al., Refined-cereal intake and risk of selected cancers in Italy. Am. J. Clin. Nutr. 1999, 70, 1107–1110.
4. Chatenoud, L., Tavani, A., La Vecchia, C., Jacobs Jr., D. R. et al., Whole grain food intake and cancer risk. Int. J. Cancer 1998, 77, 24–28.
5. Venn, B. J., Mann, J. I., Cereal grains, legumes and diabetes. Eur. J. Clin. Nutr. 2004, 58, 1443–1461.
6. Lefevre, M., Jonnalagadda, S., Effect of whole grains on markers of subclinical inflammation. Nutr. Rev. 2012, 70, 387–396.
7. Martínez I., Lattimer J. M., Hubach K. L., Case J. A. et al., Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J. 2013, 7, 269–280.
8. Katcher H. I., Legro R. S., Kunselman A. R., Gillies P. J. et al., The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am. J. Clin. Nutr. 2008, 87, 79–90.
9. Slavin, J. L., Martini, M. C., Jacobs Jr., D. R., Marquart, L., Plausible mechanisms for the protectiveness of whole grains. Am. J. Clin. Nutr. 1999, 70, 459S–463S.
10. Thompson, L. U., Antioxidants and hormone-mediated health benefits of whole grains. Crit. Rev. Food Sci. Nutr. 1994, 34, 473–497.
11. Donovan, J. L., Manach, C., Faulks, R. M., Kroon, P. A., In: Crozier, A., Clifford, M. N., Ashihara, H. (Eds.), Plant Secondary Metabolites. Occurrence, Structure and Role in the Human Diet,Blackwell Publishing, Oxford, UK 2006, pp. 303–351.
12. Del Rio, D., Costa, L. G., Lean, M. E., Crozier, A., Polyphenols and health: what compounds are involved? Nutr. Metab. Cardiovasc. Dis. 2010, 20, 1–6.
13. Selma, M. V., Espın, J. C., Thomas-Barberan, F. A., Interaction between phenolics and gut microbiota: role in human health. J. Agric. Food Chem. 2009, 57, 6485–6501.
14. Walker, A. W., Ince, J., Duncan, S. H., Webster, L. M. et al., Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011, 5, 220–230.
15. Dall'Asta, M., Calani, L., Tedeschi, M., Jechiu, L. et al., Identification of microbial metabolites derived from in vitro fecal fermentation of different polyphenolic food sources. Nutrition 2012, 28, 197–203.
16. Mateo Anson, N., Selinheimo, E., Havenaar, R., Aura, A. M. et al., Bioprocessing of wheat bran improves in vitro bioaccessibility and colonic metabolism of phenolic compounds. J. Agric. Food Chem. 2009, 57, 6148–6155.
17. Neacsu M., McMonagle, J., Fletcher R. J., Scobbie, L. et al., Bound phytophenols from ready-to-eat cereals: comparison with other plant-based foods. Food Chem. 2013, 141, 2880–2886.
18. Rubio, L., Macia, A., Motilva, M. J., Impact of various factors on pharmacokinetics of bioactive polyphenols: an overview. Curr. Drug Metab. 2014, 15, 62–76.
19. Russell, W. R., Scobbie, L., Labat, A., Duthie, G. G., Selective bio-availability of phenolic acids from Scottish strawberries. Mol. Nutr. Food Res. 2009, 53, 85–91.
20. Russell, W. R., Duncan, S. H., Scobbie, L., Duncan, G. et al., Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein. Mol. Nutr. Food Res. 2013, 57, 523–535.
21. Russell, W. R, Gratz, S. W., Duncan, S. H., Holtrop, G. et al., High protein, reduced carbohydrate weight loss diets promote metabolite profiles likely to be detrimental to colonic health. Am. J. Clin. Nutr. 2011, 93, 1062–1072.
22. Russell, W. R., Drew, J. E., Scobbie, L., Duthie G. G., Inhibition of cytokine-induced prostanoid biogenesis by phytochemicals in human colonic fibroblasts. Biochim. Biophys. Acta Mol. Basis Dis. 2006, 1762, 124–130.
23. Russell, W. R., Burkitt, M. J., Scobbie L., Chesson, A., An EPR investigation into the effects of substrate structure on peroxidase-catalysed phenylpropanoid oxidation. Biomacromolecules 2006, 7, 268–273.
24. Russell, W. R., Scobbie, L., Duthie, G. G., Chesson, A., Inhibition of 15-lipoxygenase-catalysed oxygenation of arachidonic acid by substituted benzoic acids. Bioorg. Med. Chem. 2008, 16, 4589–4593.
25. Russell, W. R., Scobbie, L., Chesson, A., Structural modification of phenylpropanoid-derived compounds and the effects on their participation in redox processes. Bioorg. Med. Chem. 2005, 13/7, 2537–2546.
26. Russell, W. R., Scobbie, L., Chesson, A., Richardson, A. J. et al., Anti-inflammatory implications of the microbial transformation of dietary phenolic compounds. Nutr. Cancer 2008, 60, 636–642.
27. Manach, C., Williamson, G., Morand, C., Scalbert, A. et al., Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81, 230S–242S.
28. Bourne, L. C., Rice-Evans, C., Bioavailability of ferulic acid. Biochem. Biophys. Res. Commun. 1998, 253, 222–227.
29. Bourne, L., Paganga, G., Baxter, D., Hughes, P. et al., Absorption of ferulic acid from low-alcohol beer. Free Radic. Res. 2000, 32, 273–280.
30. Kern, S. M., Bennett, R. N., Mellon, F. A., Kroon, P. A. et al., Absorption of hydroxycinnamates in humans after high-bran cereal consumption. J. Agric. Food Chem. 2003, 51, 6050–6055.
31. Mateo Anson, N., Aura, A. M., Selinheimo, E., Mattila, I. et al., Bioprocessing of wheat bran in whole wheat bread increases the bioavailability of phenolic acids in men and exerts antiinflammatory effects ex vivo. J. Nutr. 2011, 141, 137–143.
32. Stalmach, A., Williamson, G., Crozier, A., Impact of dose on the bioavailability of coffee chlorogenic acids in humans. Food Funct. 2014, 5, 1727–1737.
33. Vitaglione, P., Mennella, I., Ferracane, R., Rivellese, A. A. et al., Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: role of polyphenols bound to cereal dietary fiber. Am. J. Clin. Nutr. 2015 101, 251–261.
34. Sikand, G., Kris-Etherton, P. K., Boulos, N. M., Impact of functional foods on prevention of cardiovascular disease. Curr. Cardiol. Rep. 2015, 17, 17–39.
35. Vitaglione, P., Mennella, I., Ferracane, R., Rivellese, A. A. et al., Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: role of polyphenols bound to cereal dietary fiber. Am. J. Clin. Nutr. 2015 101, 251–261.
36. Bumrungpert, A., Pingeesakikul, T., Tirawanchai, N., Tuntipopipat, S. et al., Effects of ferulic acid supplementation on lipid profiles, oxidative stress and inflammatory status in hypercholesterolemic subjects. FASEB J. 2012, 26, 263.7.